Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from China Health Group ( (HK:0673) ) is now available.
China Health Group Limited has announced a further extension of the long stop date for its acquisition of ProteinT (Tianjin) Diagnostic, Co., Ltd., moving it from 28 February 2025 to 30 June 2025. This extension is due to the additional time required to prepare the necessary circular for shareholders, which has also delayed its dispatch to a new deadline of 30 June 2025. The extension suggests ongoing complexities in finalizing the acquisition, potentially impacting the company’s strategic plans and stakeholder expectations.
More about China Health Group
China Health Group Limited, operating in Hong Kong as CHG HS Limited, is incorporated in Bermuda and is listed on the Hong Kong Stock Exchange. The company is involved in the healthcare industry, focusing on the acquisition and management of healthcare-related businesses.
YTD Price Performance: -20.80%
Average Trading Volume: 1,695,460
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$97.35M
See more insights into 0673 stock on TipRanks’ Stock Analysis page.